Friday, September 19, 2014 8:32:10 AM
I have been doing extensive research and believe Dr. Casey's process would involve removing cells from a patient, growing them in a lab and then reinjection them back into the patient.
I will stand corrected but that sounds like adult stem cell therapy. As such it would be the first ever approved by the FDA and could be huge. So the answer as to what they are actually trying to get approval for is critical! Also the costs could reach the hundreds of millions of dollars!
http://stemcells.nih.gov/info/basics/pages/basics4.aspx
The National Institute of Health has already published guidelines for stem cell research but it appears to be directed more towards embryonic stem cells.
http://stemcells.nih.gov/Pages/Default.aspx
The NIH also has approved 284 stem cell lines for research going back to 2009 so it appears some colleges and companies have a big head start.
http://grants.nih.gov/stem_cells/registry/current.htm
Going even further there are companies/universities that already have approval for Phase I clinical studies. For example Tisch MSRCNY has FDA approval for the use of adult stem cells in MS patients to reverse disability.
https://www.indiegogo.com/projects/tisch-ms-center-s-fda-approved-phase-i-stem-cell-trial-for-multiple-sclerosis
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM